Showing 6 results for Depression
Bagher Larijani, Maryam Khoramshahee, Mahbobe Khalilygorgany, Fatehem Bandarian, Shahin Akhondzadeh,
Volume 3, Issue 1 (5-2004)
Abstract
Depression is one of the most prevalent mental disorders in diabetics, which affects treatment course and disease prognosis. This study focuses on the association between diabetes and depression as well as depression and glycemic control.
Methods: 375 diabetic patients (type I and II) of diabetes clinic of Doctor Shariati Hospital and diabetes association of Iran participated in this cross-sectional study.Patients were screened for depression with Beck Depression Inventory. Then depressed subjects were
evaluated with DSM IV criteria for determination of the depressive disorders category.
Results: Depression was diagnosed with Beck Depression Inventory in 41.9% of patients. Of these patients major depressive disorder was defined in 23.7%, dysthymic disorder in 9.3% and association of two disorders in 0.8% of patients. Major depressive disorder was more prevalent in 31-59 year old group and dysthymic disorder in more than 60 year age group. Also depression was more prevalent in
women, diabetics with uncontrolled blood glucose and patients with diabetes complications.
Conclusion: Depression is a prevalent psychiatric disorder in diabetics, which is associated with female gender, poor glycemic control and diabetes complications. Therefore, glycemic control and prevention and treatment of diabetes complications can prevent depressive disorders in diabetics.
Aliakbar Nejati Safa, Begher Larijani, Behnam Shariati, Homayon Amini, Adeleh Rezagholizadeh,
Volume 7, Issue 2 (9-2007)
Abstract
Background: The prevalence of depression in diabetic patients is 2-3 times more than general population. The quality of life (QOL) and glycemic control are two important outcome measures of diabetes management. The aim of this research is to study the relationship between depression, glycemic control and QOL in a sample of Iranian diabetic patients.
Methods: One hundred diabetic patients who were referred to diabetes clinic of Dr. Shariati Hospital were included in the study consecutively. The depression subscale of Hospital Anxiety and Depression Scale (HADS-D) were used to determine depression. The World Health Organization Quality of life brief version questionnaire (WHOQOL-BREF) was used to measure QOL. The status of glycemic control was evaluated through measuring HbA1c. Other measured variables included: demographic variables, smoking, diabetes type, body mass index, duration and complications of diabetes and previous history of depression. The linear regression method was implemented to analyze the data.
Results: Depression was observed in 28% of the patients. Glycemic control had a reverse significant correlation with diabetes complications. No significant relationship was found between HbA1c and scores of HADS-D. WHOQOL-BREF subscales scores had no significant relationship with glycemic control. There was a significant relation between scores of HADS-D and WHOQOL-BREF subscales.
Conclusion: Improving quality of life (QOL) is one of the main outcomes in the management of diabetes. According to the result of this study, depression had a prominent relationship with QOL. Thus, careful management of depression may be necessary to improve QOL of diabetic patients.
Kourosh Sayehmiri, Abbass Sheykhi, Forghan Rabiei Fakhr , Alireza Yadegarazadi, Milad Azami,
Volume 15, Issue 4 (5-2016)
Abstract
Background: Patients with type 2 diabetes mellitus are more prone to depression. Prevalence of depression in the Iranian results of studies is different. Therefore, the present study aims to study the prevalence of depression in Iranian patients with type II diabetes mellitus.
Methods: This study is a systematic review based on PRISMA guideline for systematic reviews and meta-analyses study. Literature searches of, Scopus, MEDLINE, PubMed, Science Direct, Cochrane, EMBASE, Web of Science, Springer, Online Library Wiley, Google Scholar search engine and Iranians database for publications in Persian and English were conducted up to December 2015. Searches were performed by two researchers independently using standard keywords. Reviewers extracted data and assessed methodological quality in duplicate. Meta-analysis was performed using STATA, version 11.1 to combine data through Random Effects Model.
Results: Sixteen studies and 3,284 subjects with a mean age of 48.6 years were included in the analysis. The prevalence of depression in Iranian patients with type II diabetes was estimated 54.8% (95% CI: 43.5- 66.1). This range for males and females were calculated 32.2 %( 95% CI: 16.3-48.1) and 60% (95% CI: 46.4-73.7), respectively. The highest prevalence of depression was in the center of Iran (60%) and the lowest rate was in the west of Iran (38%).
Conclusion: Regarding to high prevalence of depression in patients with type II diabetes, Implementation of screening program for psychiatric disorders, especially depression as well as conducted psychiatric consultation routinely for diagnosis and treatment of depression in these patients it seems necessary.
Somayeh Ramesh, Akram Alizadeh Moghdam, Ali Reza Safari, Marzieh Feizi,
Volume 18, Issue 2 (2-2019)
Abstract
Background: Diabetes mellitus is one of the most common chronic diseases and the patient's quality of life plays an important role in controlling the disease. The purpose of this study was to investigate the mediating role of quality of life in the relationship between depression, stress and anxiety, with severity of diabetes.
Methods: 108 patients with type 2 diabetes (57 women, 51 males) participated in this study. The participants completed the 21st-DASS Questionnaire, a quality of life questionnaire (SF-36), and a demographic questionnaire.
Results: The results of the study showed that the severity of the disease was negatively correlated with quality of life and positively correlated with anxiety, depression and stress (P <0.01). The results of path analysis also indicated the mediating role of quality of life in the relationship between depression and anxiety and the severity of type 2 diabetes.
Conclusion: Based on the results, it is necessary to consider psychological interventions in order to reduce depression and anxiety and improve the quality of life of patients in the field of diabetes management.
Morteza Naghipoor, Mohammad Ali Besharat,
Volume 20, Issue 2 (1-2021)
Abstract
Background: Diabetes is a common, chronic, and debilitating disease that affects millions of people worldwide, causing psychological, social and physical complications. Diagnosis of diabetes, new lifestyle and restrictive diet can pose many psychological problems, including depression for diabetic patients. The purpose of this study was to investigate the role of anger, anger rumination and alexithymia in predicting symptoms of depression.
Method: 218 patients (94 males and 124 females) with type 1 and type 2 diabetes participated in the research and were asked to complete Multidimensional Anger Inventory (MAI), Anger Rumination Scale (ARS), Toronto Alexithymia Scale (TAS-20) and Depression, Anxiety, Stress Scale (DASS).
Results: There was a positive and significant correlation between all the components of anger, anger rumination, and alexithymia with symptoms of depression, though the severity of the correlation in external anger (r=0/14**) and objective thinking (r=0/17**) was less than those of other components. Also, among the dimensions of anger, anger rumination, and alexithymia, anger arousal (p<0/05, B=0/20), angry afterthoughts (p<0/05, B=0/32), revenge thoughts (p<0/05, B=0/25), and difficulty identifying feelings (p<0/05, B=0/32) were able to predict the symptoms of depression in patients with diabetes.
Conclusion: Anger, anger rumination, and alexithymia play a major role in creating the depressive symptoms. Symptoms of depression increase the burden of the disease in patients with diabetes. Therefore, it is important to include these factors in treatment protocols and help patients with diabetes identify, describe, and express negative and positive emotions more efficiently so that they can cope with the complications of the disease better.
Asma Soleimani, Mohammad Fathi, Mostafa Bahrami,
Volume 24, Issue 3 (7-2024)
Abstract
Background: The purpose of this study was to investigate the effect of sports rehabilitation exercises with vitamin D consumption on fatigue, sleep quality and depression level of people with osteosarcoma cancer after bone marrow stem cell transplantation.
Methods: In this study, 27 women with osteosarcoma cancer with body mass index above 30 kg/m2, age 24.90±4.03 years, height 163.85±3.62 cm and weight 82.17±4.5 kg were randomly divided into four groups. (patient-exercise), (patient-exercise-vitamin D), (patient-exercise-placebo) and (control) were divided. The training protocol includes ten weeks of Pilates exercise. The supplement group took 500 IU of vitamin D three days a week for 10 weeks. Data were analyzed using dependent t-test and one-way analysis of variance.
Results: The results of the covariance analysis of the research of three exercise groups showed that after ten weeks of sports rehabilitation with vitamin D consumption, the indicators of fatigue and the level of depression decreased significantly (P≤ 0.05). Also, the results of covariance analysis of the three training groups showed that the overall sleep quality of people with osteosarcoma cancer increased significantly (P≤ 0.05). Conclusion: Based on the obtained results, it is suggested that the consumption of vitamin D along with exercise rehabilitation can be an effective treatment method for fatigue, sleep quality and depression in people with osteosarcoma cancer.
Conclusion: Based on the obtained results, it is suggested that the consumption of vitamin D along with sports rehabilitation can be an effective treatment method for fatigue, sleep quality and depression in people with osteosarcoma cancer.